2.1 Quality of life |
6 |
|
Std. Mean Difference (IV, Random, 95% CI) |
Subtotals only |
2.1.1 Quality of life: average endpoint in physical health ‐ up to 6 months |
5 |
406 |
Std. Mean Difference (IV, Random, 95% CI) |
0.55 [‐0.24, 1.33] |
2.1.2 Quality of life: average endpoint in physical health ‐ 12 months |
3 |
237 |
Std. Mean Difference (IV, Random, 95% CI) |
0.08 [‐0.18, 0.33] |
2.1.3 Quality of life: average endpoint in physical health ‐ more than 12 months |
2 |
381 |
Std. Mean Difference (IV, Random, 95% CI) |
0.02 [‐0.19, 0.24] |
2.1.4 Quality of life: average endpoint in mental health ‐ up to 6 months |
5 |
406 |
Std. Mean Difference (IV, Random, 95% CI) |
0.71 [‐0.17, 1.59] |
2.1.5 Quality of life: average endpoint in mental health component (more than 12 months) |
2 |
381 |
Std. Mean Difference (IV, Random, 95% CI) |
0.30 [‐0.10, 0.70] |
2.1.6 Quality of life: overall endpoint (WHOQOL‐BREF) ‐ 6 months |
1 |
94 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.20 [‐0.61, 0.22] |
2.1.7 Quality of life: overall endpoint (WHOQOL‐BREF) ‐ 12 months |
1 |
91 |
Std. Mean Difference (IV, Random, 95% CI) |
0.11 [‐0.31, 0.54] |
2.2 Mental state |
6 |
|
Std. Mean Difference (IV, Random, 95% CI) |
Subtotals only |
2.2.1 Mental state (overall general score) up to 6 months |
1 |
29 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.34 [‐1.07, 0.40] |
2.2.2 Mental state (general psychopathology) 6 months |
1 |
80 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.11 [‐0.55, 0.33] |
2.2.3 Mental state (general psychopathology) 12 months |
1 |
253 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.27 [‐0.53, ‐0.01] |
2.2.4 Mental state (positive symptoms) 6 months |
1 |
80 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.04 [‐0.48, 0.40] |
2.2.5 Mental state (positive symptoms) 12 months |
1 |
253 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.17 [‐0.43, 0.09] |
2.2.6 Mental state (negative symptoms) 6 months |
1 |
80 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.26 [‐0.70, 0.18] |
2.2.7 Mental state (negative symptoms) 12 months |
1 |
253 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.08 [‐0.34, 0.18] |
2.2.8 Mental state (depressive symptoms) up to 6 months |
4 |
259 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.13 [‐0.53, 0.27] |
2.2.9 Mental state (depressive symptoms) 12 months |
3 |
227 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.17 [‐0.53, 0.18] |
2.2.10 Mental state (depressive symptoms) more than 12 months |
1 |
75 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.19 [‐0.64, 0.27] |
2.2.11 Mental state (manic symptoms) up to 6 months |
3 |
230 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.14 [‐0.40, 0.12] |
2.2.12 Mental state (manic symptoms) 12 months |
3 |
227 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.08 [‐0.38, 0.22] |
2.2.13 Mental state (manic symptoms) more than 12 months |
1 |
75 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.36 [‐0.82, 0.10] |
2.3 Psychiatric hospital admissions: number of participants admitted to hospital (greater than 12 months) |
1 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
2.3.1 Number of participants admitted to hospital (in year 2) |
1 |
306 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.75 [0.57, 0.99] |
2.3.2 Number of participants admitted to hospital (in year 3) |
1 |
306 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.73 [0.53, 1.01] |
2.4 Other hospital admissions |
2 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
2.4.1 Number of participants admitted to hospital (up to 12 months) |
1 |
253 |
Risk Ratio (M‐H, Fixed, 95% CI) |
7.77 [0.45, 134.42] |
2.4.2 Number of participants admitted to hospital (in year 2) |
1 |
306 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.83 [0.65, 1.04] |
2.4.3 Number of participants admitted to hospital (in year 3) |
1 |
306 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.70 [0.53, 0.93] |
2.5 Personal recovery |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
Not estimable |
2.6 Physical health status |
3 |
|
Std. Mean Difference (IV, Random, 95% CI) |
Subtotals only |
2.6.1 Blood pressure, mmHg systolic ‐ up to 6 months |
3 |
165 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.15 [‐0.54, 0.24] |
2.6.2 Blood pressure, mmHg systolic ‐ 12 months |
2 |
136 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.20 [‐0.54, 0.13] |
2.6.3 Blood pressure, mmHg systolic ‐ 24 months |
1 |
75 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.22 [‐0.67, 0.24] |
2.6.4 Blood pressure, mmHg diastolic ‐ 6 months |
2 |
136 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.25 [‐0.77, 0.27] |
2.6.5 Blood pressure, mmHg diastolic ‐ 12 months |
2 |
136 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.29 [‐0.70, 0.12] |
2.6.6 Blood pressure, mmHg diastolic ‐ 24 months |
1 |
75 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.25 [‐0.70, 0.21] |
2.6.7 Body mass index (BMI) ‐ 6 months |
3 |
165 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.18 [‐0.50, 0.15] |
2.6.8 BMI ‐ 12 months |
2 |
136 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.37 [‐0.71, ‐0.03] |
2.6.9 BMI ‐ 24 months |
1 |
75 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.35 [‐0.81, 0.11] |
2.6.10 Total cholesterol ‐ 6 months |
1 |
71 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.43 [‐0.90, 0.04] |
2.6.11 Total cholesterol ‐ 12 months |
1 |
71 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.19 [‐0.65, 0.28] |
2.6.12 Total cholesterol ‐ 24 months |
1 |
75 |
Std. Mean Difference (IV, Random, 95% CI) |
0.07 [‐0.39, 0.52] |
2.6.13 Triglycerides up to 6 months |
1 |
29 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.35 [‐1.09, 0.38] |
2.6.14 High‐density lipoprotein (HDL) ‐ 6 months |
1 |
71 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.06 [‐0.52, 0.41] |
2.6.15 High‐density lipoprotein (HDL) ‐ 12 months |
1 |
71 |
Std. Mean Difference (IV, Random, 95% CI) |
0.10 [‐0.36, 0.57] |
2.6.16 High‐density lipoprotein (HDL) ‐ 24 months |
1 |
75 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.19 [‐0.64, 0.27] |
2.6.17 Low‐density lipoprotein (LDL) ‐ 6 months |
2 |
100 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.34 [‐0.73, 0.06] |
2.6.18 Low‐density lipoprotein (LDL) ‐ 12 months |
1 |
71 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.12 [‐0.59, 0.34] |
2.6.19 Low‐density lipoprotein (LDL) ‐ 24 months |
1 |
75 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.00 [‐0.46, 0.45] |
2.6.20 HbA1c up to 6 months |
1 |
29 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.37 [‐1.10, 0.37] |
2.6.21 Waist circumference ‐ 6 months |
2 |
136 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.31 [‐0.98, 0.35] |
2.6.22 Waist circumference ‐ 12 months |
2 |
136 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.39 [‐0.75, ‐0.03] |
2.6.23 Waist circumference ‐ 24 months |
1 |
75 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.29 [‐0.75, 0.17] |
2.7 Global state |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
Not estimable |
2.8 Medication adherence (patient‐reported) (DAI‐10) |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
2.8.1 Medication adherence (patient at 6 months) |
1 |
94 |
Risk Ratio (M‐H, Random, 95% CI) |
0.83 [0.67, 1.04] |
2.8.2 Medication adherence (patient at 12 months) |
1 |
91 |
Risk Ratio (M‐H, Random, 95% CI) |
0.91 [0.75, 1.11] |
2.9 Medication adherence (patient‐reported) (MARS) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Subtotals only |
2.9.1 Medication adherence (up to 6 months) |
1 |
96 |
Mean Difference (IV, Fixed, 95% CI) |
1.79 [1.56, 2.02] |
2.10 Social functioning (binary) |
1 |
253 |
Risk Ratio (M‐H, Random, 95% CI) |
1.38 [0.97, 1.95] |
2.11 Social functioning/disability |
4 |
|
Std. Mean Difference (IV, Random, 95% CI) |
Subtotals only |
2.11.1 Social functioning/disability (up to 6 months) |
3 |
230 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.14 [‐0.61, 0.32] |
2.11.2 Social functioning/disability ‐ 12 months |
4 |
480 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.16 [‐0.44, 0.12] |
2.11.3 Social functioning/disability (more than 12 months) |
1 |
75 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.14 [‐0.59, 0.32] |
2.12 Substance use (alcohol/illicit drugs/cigarettes/tobacco) |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
Not estimable |
2.13 Adverse effect/event(s) |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
Not estimable |
2.14 Death |
4 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
2.14.1 Number of participants that died from suicide (36 months) |
1 |
330 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.33 [0.01, 8.03] |
2.14.2 Number of participants that died from natural causes (36 months) |
1 |
330 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.48 [0.62, 3.53] |
2.14.3 Number of participants that died from suicide (12 months) |
1 |
273 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.53 [0.03, 8.30] |
2.14.4 Death from natural causes (6 months) |
1 |
35 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.32 [0.01, 7.26] |
2.14.5 Any deaths (12 months) |
1 |
118 |
Risk Ratio (M‐H, Fixed, 95% CI) |
5.17 [0.25, 105.42] |
2.15 Service use outside of mental health (i.e. primary care, emergency services, walk‐in centres, social services) |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
Not estimable |
2.16 Cost of treatment |
1 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
2.16.1 Intervention costs (at 36 months) |
1 |
306 |
Mean Difference (IV, Random, 95% CI) |
‐2.98 [‐16.93, 10.97] |
2.17 Cost of treatment (international dollars) |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
493.00 [345.41, 640.59] |
2.17.1 Total costs at 12 months |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
493.00 [345.41, 640.59] |
2.18 Experience of care/satisfaction |
0 |
0 |
Risk Ratio (M‐H, Fixed, 95% CI) |
Not estimable |
2.19 Attrition/leaving the study early |
6 |
|
Risk Ratio (M‐H, Fixed, 95% CI) |
Subtotals only |
2.19.1 Attrition/leaving the study early (lost to follow‐up 6 months) |
3 |
235 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.39 [0.76, 2.55] |
2.19.2 Attrition/leaving the study early (lost to follow‐up 12 months) |
3 |
504 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.11 [0.77, 1.58] |
2.19.3 Attrition/leaving the study early (lost to follow‐up 24 months) |
1 |
118 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.19 [0.74, 1.92] |
2.19.4 Attrition/leaving the study early (lost to follow‐up at 36 months) |
1 |
330 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.71 [0.77, 3.79] |